Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
Open Access
- 19 April 2018
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 173 (4), 864-878.e29
- https://doi.org/10.1016/j.cell.2018.03.028
Abstract
No abstract availableFunding Information
- NIH (CA197717, CA176284, CA70907, CA142543)
- CPRIT (RP120732, RP110708, RP110708)
- Robert Welch Foundation (I-1414)
- Korea Health Technology R & D
- Korea Health Industry Development Institute (HI14C1324)
- National R&D Program for Cancer Control (1420100)
- Ministry of Health & Welfare, Republic of Korea
- NIH (5T32GM8203-27)
- CPRIT (RP140110)
- NIH (5T32CA124334-09)
This publication has 36 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stressNature, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesisNature Genetics, 2011
- TTC21B contributes both causal and modifying alleles across the ciliopathy spectrumNature Genetics, 2011
- Glucocorticoid use in acute lymphoblastic leukaemiaThe Lancet Oncology, 2010
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005